| Literature DB >> 30013061 |
Timm Fehrentz1, Florian M E Huber2,3, Nina Hartrampf2, Tobias Bruegmann4,5, James A Frank2,6, Nicholas H F Fine7,8, Daniela Malan4, Johann G Danzl9,10, Denis B Tikhonov11, Martin Sumser2, Philipp Sasse4, David J Hodson7,8, Boris S Zhorov11,12,13, Nikolaj Klöcker14, Dirk Trauner15,16.
Abstract
L-type Ca2+ channels (LTCCs) play a crucial role in excitation-contraction coupling and release of hormones from secretory cells. They are targets of antihypertensive and antiarrhythmic drugs such as diltiazem. Here, we present a photoswitchable diltiazem, FHU-779, which can be used to reversibly block endogenous LTCCs by light. FHU-779 is as potent as diltiazem and can be used to place pancreatic β-cell function and cardiac activity under optical control.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30013061 DOI: 10.1038/s41589-018-0090-8
Source DB: PubMed Journal: Nat Chem Biol ISSN: 1552-4450 Impact factor: 15.040